Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
Go back to Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer| (NASDAQ: EWTX) | Delayed: 42.90 -0.49 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.39 | 52 Week High | $ | |||
| Open | $42.82 | 52 Week Low | $ | |||
| Day High | $43.50 | P/E | N/A | |||
| Day Low | $42.35 | EPS | $ | |||
| Volume | 788,590 | |||||
